Bodner, US
Darren Bodner, Chicago, IL US
Patent application number | Description | Published |
---|---|---|
20140263497 | WEAPON SAFETY DEVICE - Disclosed is a safety device that maintains a weapon inside a holster in a locked state without requiring the gun to be removed from the holster beforehand. In the embodiments, a single safety device can be used on a variety of holsters to lock the gun inside the holster, without requiring removal of the gun from the holster, therefore preventing children or other unauthorized individuals from accessing the gun and the gun's trigger. | 09-18-2014 |
20150233672 | Weapon Safety Device - Disclosed is a safety device that maintains a weapon inside a holster in a locked state without requiring the gun to be removed from the holster beforehand. In the embodiments, a single safety device can be used on a variety of holsters to lock the gun inside the holster, without requiring removal of the gun from the holster, therefore preventing children or other unauthorized individuals from accessing the gun and the gun's trigger. | 08-20-2015 |
Janet Ellen Bodner, Bernardsville, NJ US
Patent application number | Description | Published |
---|---|---|
20110105575 | METHOD OF TREATMENT OF HEREDITARY HEMOCHROMATOSIS - The present invention relates to the use of Compound I of the following formula | 05-05-2011 |
20110294861 | METHOD OF TREATMENT OF HEREDITARY HEMOCHROMATOSIS - The present invention relates to the use of Compound I of the following formula | 12-01-2011 |
Jeffrey P. Bodner, Plymouth, MN US
Patent application number | Description | Published |
---|---|---|
20130287275 | Volume Of Efficacy Model Capture - A system and method for determining, planning, and/or administering a therapy of a selected material from a catheter to a selected specific region of an anatomy is disclosed. The catheter can be used to deliver a drug to the patient to achieve a volume of efficacy (VOE) within a selected target, region, or volume. The drug delivered can be used for treating at least a symptom in the patient. | 10-31-2013 |
20140276416 | Socketed Portal Anchors and Methods of Using Same - Anchors for securing a medical device relative to a body portal, wherein the anchors may accommodate most any implantation trajectory through the portal. Such anchors may further secure the device along any such trajectory without imparting undesirable biasing forces that may shift the device from its intended implanted location. In some embodiments, the anchor is configured as a burr hole anchor including a spherical member contained in a socket of the anchor such that orientation of the spherical member is permitted about three mutually perpendicular axes. | 09-18-2014 |
20140276418 | Socketed Portal Anchors and Methods of Using Same - Anchors for securing a medical device relative to a body portal, wherein the anchors may accommodate most any implantation trajectory through the portal. Such anchors may further secure the device along any such trajectory without imparting undesirable biasing forces that may shift the device from its intended implanted location. In some embodiments, the anchor is configured as a burr hole anchor including a spherical member contained in a socket of the anchor wherein the socket may be collapsed to lock the spherical member along a particular trajectory. | 09-18-2014 |
20140276529 | Portal Anchors Incorporating Strain Relief Cup and Systems Using Same - Anchors for securing a medical device relative to a burr hole, wherein the anchors may accommodate most any implantation trajectory through the burr hole. Such anchors may further secure the device along any such trajectory without imparting undesirable biasing forces that may shift the device from its intended implanted location. In some embodiments, the anchor is configured with a cup-shaped retention member through which the medical device passes. The retention member may receive a volume of curable material therein to provide strain relief to the medical device. | 09-18-2014 |
Jeffrey P. Bodner, St. Paul, MN US
Patent application number | Description | Published |
---|---|---|
20090125058 | LEAD STABILIZER WITH RETENTION FEATURES - An anchoring device for anchoring a medical lead implanted in a patient includes a substantially elongate, hollow, tubular, and elastically compressible body. The body has a longitudinal axis, a groove formed circumferentially about the body for receiving a suture and an inner bore forming a recessed portion. The anchoring device also has a surrounding portion adjacent the recessed portion, where the recessed portion has increased retention characteristics on a medical lead relative to the surrounding portion of the inner bore. | 05-14-2009 |
20110137383 | IMPLANTABLE LEADS PERMITTING FUNCTIONAL STATUS MONITORING - An implantable lead assembly includes a lead body extending from a proximal end to a distal end having an intermediate portion therebetween, where the lead body includes an insulating layer. A conductor is disposed within the insulating layer and the insulating layer surrounds the conductor. An electrode is coupled to the lead body, and the electrode is in electrical communication with the conductor. At least one conductive sleeve is disposed within the insulating layer. The at least one conductive sleeve surrounds the conductor and is electrically isolated from the electrode. The at least one conductive sleeve has a first impedance value in a first condition. | 06-09-2011 |
20110166522 | ACCUMULATOR FOR THERAPEUTIC FLUID DELIVERY DEVICES - A therapeutic fluid delivery device includes a flexible member configured as an accumulator for flow of a therapeutic fluid through the fluid delivery device to a patient. In one example, the flexible member includes a catheter access port (CAP) septum. | 07-07-2011 |
20130096503 | ACCUMULATOR FOR IMPLANTABLE INFUSION DEVICE - An accumulator is employed in an implantable infusion device to provide compliance in the flow path of the device. The accumulator may act to increase the pumping accuracy and repeatability while simultaneously reducing the energy requirements of the device. In one example, the accumulator is arranged at the outlet of a fluid delivery pump of the infusion device. The accumulator includes a cover and a diaphragm biased away from the cover and configured to deflect toward the cover under pressure generated by the therapeutic agent in a flow path of the infusion device. The cover of the accumulator is configured to withstand the pressure generated by the therapeutic agent in the flow path without deforming. | 04-18-2013 |
20140343620 | LEADLESS CARDIAC STIMULATION DEVICE EMPLOYING DISTRIBUTED LOGIC - Systems and methods involve an intrathoracic cardiac stimulation device operable to provide autonomous cardiac sensing and energy delivery. The cardiac stimulation device includes a housing configured for intrathoracic placement relative to a patient's heart. A fixation arrangement of the housing is configured to affix the housing at an implant location within cardiac tissue or cardiac vasculature. An electrode arrangement supported by the housing is configured to sense cardiac activity and deliver stimulation energy to the cardiac tissue or cardiac vasculature. Energy delivery circuitry in the housing is coupled to the electrode arrangement. Detection circuitry is provided in the housing and coupled to the electrode arrangement. Communications circuitry may optionally be supported by the housing. A controller in the housing coordinates delivery of energy to the cardiac tissue or cardiac vasculature in accordance with an energy delivery protocol appropriate for the implant location. | 11-20-2014 |
20150328473 | LEADLESS CARDIAC STIMULATION DEVICE EMPLOYING DISTRIBUTED LOGIC - Systems and methods involve an intrathoracic cardiac stimulation device operable to provide autonomous cardiac sensing and energy delivery. The cardiac stimulation device includes a housing configured for intrathoracic placement relative to a patient's heart. A fixation arrangement of the housing is configured to affix the housing at an implant location within cardiac tissue or cardiac vasculature. An electrode arrangement supported by the housing is configured to sense cardiac activity and deliver stimulation energy to the cardiac tissue or cardiac vasculature. Energy delivery circuitry in the housing is coupled to the electrode arrangement. Detection circuitry is provided in the housing and coupled to the electrode arrangement. Communications circuitry may optionally be supported by the housing. A controller in the housing coordinates delivery of energy to the cardiac tissue or cardiac vasculature in accordance with an energy delivery protocol appropriate for the implant location. | 11-19-2015 |
Jonathan Bodner, Potomac, MD US
Patent application number | Description | Published |
---|---|---|
20110202555 | Graphical User Interfaces Supporting Method And System For Electronic Discovery Using Social Network Analysis - A method, for use in a user computer system including a pointing device and a visual display unit, for providing a graphical user interface to a computer program for electronic discovery of information, wherein the information is stored in a database, and wherein the information has been preprocessed using social network analysis to find social network relationships between items of the information, and wherein topics are determined using distributed Latent Dirichlet Allocation (LDA) | 08-18-2011 |
Keith Bodner, Norton, MA US
Patent application number | Description | Published |
---|---|---|
20110119959 | EXTERNAL STABILIZING STRUCTURE FOR WORK BOOTS - The external stabilizing structure is a structural element for use in work boots and similar types of footwear. The external stabilizing structure comprises a molded footbed of firm yet flexible material that provides external support under both the heel and arch of the wearer's foot. | 05-26-2011 |
Kevin Bodner, Belmont, CA US
Patent application number | Description | Published |
---|---|---|
20090176661 | WHOLE GENOME EXPRESSION ANALYSIS SYSTEM - A method for simultaneously determining a genetic expression profile for an individual member of a species relative to an entire standard genome for the species. The method can comprise distributing a liquid sample into an array of reaction chambers of a substrate. The array can comprise a primer set and a probe for each polynucleotide target along the entire standard genome. The liquid sample can comprise substantially all genetic material of the member. Each of the reaction chambers can comprise the primer set and the probe for at least one of the polynucleotide targets and a polymerase. The method can further comprise amplifying the liquid sample in the array, detecting a signal emitted by at least one of the probes, and identifying the genetic expression profile in response to the signal. | 07-09-2009 |
20130210674 | WHOLE GENOME EXPRESSION ANALYSIS SYSTEM - A method for simultaneously determining a genetic expression profile for an individual member of a species relative to an entire standard genome for the species. The method can comprise distributing a liquid sample into an array of reaction chambers of a substrate. The array can comprise a primer set and a probe for each polynucleotide target along the entire standard genome. The liquid sample can comprise substantially all genetic material of the member. Each of the reaction chambers can comprise the primer set and the probe for at least one of the polynucleotide targets and a polymerase. The method can further comprise amplifying the liquid sample in the array, detecting a signal emitted by at least one of the probes, and identifying the genetic expression profile in response to the signal. | 08-15-2013 |
Kevin S. Bodner, Foster City, CA US
Patent application number | Description | Published |
---|---|---|
20150238919 | Microfluidic Devices And Method For Their Use - Exemplary embodiments provide microfluidic devices and methods for their use. The microfluidic device can include an array of M×N reaction sites formed by intersecting a first and second plurality of fluid channels of a flow layer. The flow layer can have a matrix design and/or a blind channel design to analyze a large number of samples under a limited number of conditions. The microfluidic device can also include a control layer including a valve system for regulating solution flow through fluid channels. In addition, by aligning the control layer with the fluid channels, the detection of the microfluidic devices, e.g., optical signal collection, can be improved by piping lights to/from the reaction sites. In an exemplary embodiment, guard channels can be included in the microfluidic device for thermal cycling and/or reducing evaporation from the reaction sites. | 08-27-2015 |
Kevin S. Bodner, Belmont, CA US
Patent application number | Description | Published |
---|---|---|
20090000690 | Diffusion-aided loading system for microfluidic devices - Microfluidic devices having a diffusion-aided system for loading samples into the microfluidic device are provided. Methods of gas-venting a microfluidic device through a non-porous, gas permeable material sealing cover layer, for example, during liquid sample loading, are also provided. The non-porous, gas-permeable material can be, for example, a polysiloxane, for example, polydimethylsiloxane. | 01-01-2009 |
20110085168 | Luminescence Reference Standards - The present teachings provide for systems, and components thereof, for detecting and/or analyzing light. These systems can include, among others, optical reference standards utilizing luminophores, such as nanocrystals, for calibrating, validating, and/or monitoring light-detection systems, before, during, and/or after sample analysis. | 04-14-2011 |
20130224877 | LUMINESCENCE REFERENCE STANDARDS - The present teachings provide for systems, and components thereof, for detecting and/or analyzing light. These systems can include, among others, optical reference standards utilizing luminophores, such as nanocrystals, for calibrating, validating, and/or monitoring light-detection systems, before, during, and/or after sample analysis. | 08-29-2013 |
20140284496 | LUMINESCENCE REFERENCE STANDARDS - The present teachings provide for systems, and components thereof, for detecting and/or analyzing light. These systems can include, among others, optical reference standards utilizing luminophores, such as nanocrystals, for calibrating, validating, and/or monitoring light-detection systems, before, during, and/or after sample analysis. | 09-25-2014 |
20150015876 | Luminescence Reference Standards - The present teachings provide for systems, and components thereof, for detecting and/or analyzing light. These systems can include, among others, optical reference standards utilizing luminophores, such as nanocrystals, for calibrating, validating, and/or monitoring light-detection systems, before, during, and/or after sample analysis. | 01-15-2015 |
20150111200 | Luminescence Reference Standards - The present teachings provide for systems, and components thereof, for detecting and/or analyzing light. These systems can include, among others, optical reference standards utilizing luminophores, such as nanocrystals, for calibrating, validating, and/or monitoring light-detection systems, before, during, and/or after sample analysis. | 04-23-2015 |
20150269756 | Visualization Tools For Digital PCR Data - A method for generating a data visualization is provided. The method includes displaying a representation of a portion of detected data from a substrate to a user. The method further includes generating a data quality value for the portion of detected data and displaying, along with the representation of the portion of detected data, an indication of data quality value for the portion of detected data. The method further includes selecting, by the user, a quality value threshold, and displaying an adjusted indication of data quality value for the portion of detected data meeting the quality value threshold. | 09-24-2015 |
Mark Bodner, Placentia, CA US
Patent application number | Description | Published |
---|---|---|
20090325137 | SYSTEM AND METHOD FOR TRAINING WITH A VIRTUAL APPARATUS - A method and system of training in conjunction with a computer animation executed by a computing environment is described. The method includes recognizing a task to be performed in the computer animation, recognizing a problem, displayed in the computer animation, to accomplish the task, and solving the problem by manipulation of a virtual apparatus having virtual components displayed in the computer animation. The virtual components are manipulated by a student or user desiring to learn. The student is taught to understand logically consistent goals by using the virtual apparatus and without language interaction. Rules and properties for a subject area are modeled to the student by the virtual apparatus without language interaction. The student is taught to operate the virtual apparatus without language interaction. The student is requested to operate the virtual apparatus to reach goals in a sequence of problems having progressive difficulty and without language interaction. | 12-31-2009 |
Micah J. Bodner, Vida, OR US
Patent application number | Description | Published |
---|---|---|
20130281462 | ARYL DIAMIDINES AND PRODRUGS THEREOF FOR TREATING MYOTONIC DYSTROPHY - Disclosed herein are compounds (for example, diamidine derivatives and prodrugs) and methods of use thereof, for example in treating muscular dystrophy (DM) or disease caused by a toxic RNA in a subject. In some embodiments, the methods include administering an effective amount of one of more of the disclosed compounds to a subject to treat or inhibit DM or a disease caused by or associated with toxic RNA, such as DM1, DM2, spinocerebellar ataxia type 8 (SCA8), fragile X tremor ataxia syndrome (FXTAS), or Huntington disease-like 2 (HLD2). In some examples, the methods include selecting a subject for treatment, for example selecting a subject with DM1, DM2, SCA8, FXTAS, or HLD2. | 10-24-2013 |
Micah Jeffrey Bodner, Dexter, OR US
Patent application number | Description | Published |
---|---|---|
20130066066 | Method for Late Introduction of the (8R)-Hydroxyl Group Carbapenem Beta-Lactam Antibiotic Synthesis - The presently disclosed subject matter demonstrates that ThnG and ThnQ enzymes encoded by the thienamycin gene cluster in | 03-14-2013 |
Michael Bodner, Ann Arbor, MI US
Patent application number | Description | Published |
---|---|---|
20080222040 | Disaggregation/reassembly method system for information rights management of secure documents - The present invention pertains to a computerized system and method that provides for the secure storage and retrieval of electronic digital healthcare information; and, more particularly, to such a computerized system and method that provides for multiple access levels of such secure information; provides for secure access to portions of secure information dependent upon access privileges of the authorized user; provides virtually limitless data expansion capabilities; and provides for rapid access to such secure information by authorized users. | 09-11-2008 |
20080294895 | Disaggregation/reassembly method system for information rights management of secure documents - The present invention pertains to a computerized system and method that provides for the secure storage and retrieval of electronic digital information; and, more particularly, to such a computerized system and method that provides for multiple access levels of such secure information; provides for secure access to portions of secure information dependent upon access privileges of the authorized user; provides virtually limitless data expansion capabilities; and provides for rapid access to such secure information by authorized users. | 11-27-2008 |
Michelle Bodner, New York, NY US
Patent application number | Description | Published |
---|---|---|
20150360823 | CHILD PROOF CONTAINERS - Child proof containers are provided. In some embodiments, the child proof container comprise: a removal tool having a first end; a pouch with a first edge and a second edge that together form an opening to the pouch; a first handle portion that is attached to the first edge and that includes an opening sized to receive the first end of the removal tool; a second handle portion that is attached to the second edge, that is configured to fit into a cavity in the first handle portion, that interlocks with the first handle portion when in the cavity, and that can be pushed out of the first handle portion using the first end of the removal tool. | 12-17-2015 |
Moishe Bodner, Brooklyn, NY US
Patent application number | Description | Published |
---|---|---|
20100099127 | SYSTEM AND METHOD FOR ACQUIRING AND STORING BIOLOGICAL SAMPLES - A system and method that may include grasping a sample collection medium with a holder; inserting the sample collection medium into a medium storage device within a first container such that at least a first portion of the sample collection medium is securely held within the first container; separating a second portion of the sample collection medium retained within the holder from the first portion of the sample collection medium held within the first container; and inserting the second portion of the sample collection medium into a second container. | 04-22-2010 |
20130344615 | FLUID SAMPLING APPARATUS AND COLLECTOR PAD SPLITTER - A fluid sampling apparatus having a container and a splitter disposed in the container. The splitter is operative for dividing an absorbent pad of a sample collector into two portions. The splitter may have a base and clamping arrangement connected to the base. The clamping arrangement is operative for clamping onto a first portion of the absorbent pad so that the first portion of the absorbent pad can be separated from a second portion of the absorbent pad by pulling the sample collector away from the splitter. | 12-26-2013 |
Rena Bodner, New York, NY US
Patent application number | Description | Published |
---|---|---|
20090042926 | Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment - The present invention encompasses compounds of Formula (I): as well as pharmaceutically acceptable salts and hydrates thereof, that are useful for treating atherosclerosis, dyslipidemias and the like. Pharmaceutical compositions and methods of use are also included. | 02-12-2009 |
Renata F. Bodner, Tinton Falls, NJ US
Patent application number | Description | Published |
---|---|---|
20080201462 | Distributed Network Management System and Method - A system and method for method of managing a network. Each of a plurality of servers includes an element management system (EMS) function for managing network elements within the network and a network management system (NMS) function for managing ones of the plurality of servers running the EMS function. An NMS function is activated on one of the servers when the plurality of servers shares a one network domain. When the network domain is divided into multiple domains, e.g. by a network failure, an NMS function is activated on at least one other one of the plurality of servers whereby each of the multiple network domains has at least one associated active NMS function. | 08-21-2008 |